Patrick Sven Plum

2.1k total citations
90 papers, 1.2k citations indexed

About

Patrick Sven Plum is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Patrick Sven Plum has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Surgery, 43 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Patrick Sven Plum's work include Esophageal Cancer Research and Treatment (39 papers), Gastric Cancer Management and Outcomes (32 papers) and Esophageal and GI Pathology (19 papers). Patrick Sven Plum is often cited by papers focused on Esophageal Cancer Research and Treatment (39 papers), Gastric Cancer Management and Outcomes (32 papers) and Esophageal and GI Pathology (19 papers). Patrick Sven Plum collaborates with scholars based in Germany, Denmark and United States. Patrick Sven Plum's co-authors include Arnulf H. Hölscher, Christiane J. Bruns, Seung‐Hun Chon, Elfriede Bollschweiler, Felix Berlth, Hakan Alakus, Robert Kleinert, Stefan Mönig, Alexander Quaas and Henrik Dam and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Patrick Sven Plum

78 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Sven Plum Germany 20 561 478 258 231 164 90 1.2k
Shaokun Chuai United States 16 342 0.6× 394 0.8× 368 1.4× 435 1.9× 168 1.0× 29 1.8k
Gavitt A. Woodard United States 16 415 0.7× 486 1.0× 272 1.1× 199 0.9× 141 0.9× 57 1.2k
Tom Florian Ulmer Germany 23 847 1.5× 320 0.7× 147 0.6× 371 1.6× 145 0.9× 102 1.5k
Oscar Matzinger Switzerland 18 361 0.6× 546 1.1× 111 0.4× 193 0.8× 127 0.8× 56 1.1k
Luis Miguel Marín Gómez Spain 19 721 1.3× 197 0.4× 234 0.9× 158 0.7× 105 0.6× 86 1.6k
Benedito Borges da Silva Brazil 17 270 0.5× 167 0.3× 120 0.5× 165 0.7× 111 0.7× 76 963
Li Yin Sweden 17 434 0.8× 164 0.3× 158 0.6× 159 0.7× 85 0.5× 42 1.4k
Duncan Spalding United Kingdom 21 463 0.8× 221 0.5× 257 1.0× 526 2.3× 101 0.6× 78 1.4k
Marco Carbone Italy 26 1.1k 1.9× 258 0.5× 187 0.7× 229 1.0× 78 0.5× 132 2.4k
Roland Seiler Switzerland 27 1.2k 2.1× 615 1.3× 635 2.5× 473 2.0× 289 1.8× 108 2.1k

Countries citing papers authored by Patrick Sven Plum

Since Specialization
Citations

This map shows the geographic impact of Patrick Sven Plum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Sven Plum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Sven Plum more than expected).

Fields of papers citing papers by Patrick Sven Plum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Sven Plum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Sven Plum. The network helps show where Patrick Sven Plum may publish in the future.

Co-authorship network of co-authors of Patrick Sven Plum

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Sven Plum. A scholar is included among the top collaborators of Patrick Sven Plum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Sven Plum. Patrick Sven Plum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehdorn, Matthias, et al.. (2025). Funktionelle Folgen von Radiotherapie, Chemotherapie und Operation bei der Behandlung des Rektumkarzinoms. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 150(4). 353–361.
2.
Mehdorn, Matthias, Anne-Kathrin Höhn, Stefan Niebisch, et al.. (2024). Diagnostic Accuracy and Reliability of CT-based Node-RADS for Esophageal Cancer. In Vivo. 39(1). 353–359. 1 indexed citations
3.
Plum, Patrick Sven, Stefan Mönig, Ines Gockel, Gisela Keller, & Katja Ott. (2024). Gendermedizin bei Erkrankungen des oberen Gastrointestinaltrakts. Die Chirurgie. 95(9). 685–695.
4.
Plum, Patrick Sven, Stefan Niebisch, & Ines Gockel. (2024). State-of-the-Art Surgery in Achalasia. Visceral Medicine. 40(6). 1–6.
5.
Gebauer, Florian, Patrick Sven Plum, Alexander Damanakis, et al.. (2023). Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction. Annals of Surgical Oncology. 30(12). 7422–7433. 7 indexed citations
6.
Damanakis, Alexander, Patrick Sven Plum, Florian Gebauer, et al.. (2022). Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 148(9). 2287–2293. 4 indexed citations
7.
Zhou, Chenghui, Zhefang Wang, Jiahui Li, et al.. (2021). Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification. Cancers. 13(10). 2403–2403. 20 indexed citations
8.
9.
Brinkmann, Sebastian, Hans F. Fuchs, Arnulf H. Hoelscher, et al.. (2021). Short- and long-term follow-up of patients with non-neoplastic esophageal perforation. Langenbeck s Archives of Surgery. 407(2). 569–577. 3 indexed citations
10.
Plum, Patrick Sven, Heike Löser, Thomas Zander, et al.. (2020). GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy. Journal of Cancer Research and Clinical Oncology. 147(4). 1031–1040. 5 indexed citations
11.
Plum, Patrick Sven, Florian Gebauer, Maxwell Kramer, et al.. (2019). HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma. BMC Cancer. 19(1). 38–38. 57 indexed citations
12.
Bürger, Martin, Till Herbold, Sven Lange, et al.. (2019). In Vitro Evaluation of Mechanical Properties of Segmented Esophageal Self-Expandable Metal Stents: Innovative Test Methods Are Needed. Journal of Laparoendoscopic & Advanced Surgical Techniques. 29(9). 1168–1173. 3 indexed citations
13.
Schiffmann, Lars M., Heike Göbel, Heike Löser, et al.. (2019). Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma. BMC Cancer. 19(1). 531–531. 12 indexed citations
14.
Damanakis, Alexander, Luisa M. Ostertag, Dirk Waldschmidt, et al.. (2019). Proposal for a definition of "Oligometastatic disease in pancreatic cancer". BMC Cancer. 19(1). 1261–1261. 33 indexed citations
15.
Favi, Francesco, E. Bollschweiler, Felix Berlth, et al.. (2017). Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study. European Journal of Surgical Oncology. 43(8). 1572–1580. 22 indexed citations
16.
Kleinert, Robert, Roger Wahba, De‐Hua Chang, et al.. (2015). 3D Immersive Patient Simulators and Their Impact on Learning Success: A Thematic Review. Journal of Medical Internet Research. 17(4). e91–e91. 38 indexed citations
17.
Berlth, Felix, Stefan Mönig, Peter Grimminger, et al.. (2015). Both GLUT-1 and GLUT-14 are Independent Prognostic Factors in Gastric Adenocarcinoma. Annals of Surgical Oncology. 22(S3). 822–831. 30 indexed citations
18.
Kaemmerer, Elke, Ursula Schneider, Patrick Sven Plum, et al.. (2014). TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas. Cell and Tissue Research. 357(1). 267–278. 13 indexed citations
19.
Plum, Patrick Sven, Elfriede Bollschweiler, A. H. Hölscher, & Ute Warnecke‐Eberz. (2013). Novel diagnostic and prognostic biomarkers in esophageal cancer. Expert Opinion on Medical Diagnostics. 7(6). 557–571. 9 indexed citations
20.
Metzger, Ralf, Dietmar Lorenz, Ines Gockel, et al.. (2013). pT2 Adenocarcinoma of the Esophagus: Early or Advanced Cancer?. The Annals of Thoracic Surgery. 96(5). 1840–1845. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaokun Chuai Breakdown of academic impact, for papers by Gavitt A. Woodard Breakdown of academic impact, for papers by Tom Florian Ulmer Breakdown of academic impact, for papers by Oscar Matzinger Breakdown of academic impact, for papers by Luis Miguel Marín Gómez Breakdown of academic impact, for papers by Benedito Borges da Silva Breakdown of academic impact, for papers by Li Yin Breakdown of academic impact, for papers by Duncan Spalding Breakdown of academic impact, for papers by Marco Carbone Breakdown of academic impact, for papers by Roland Seiler
Rankless by CCL
2026